Press "Enter" to skip to content

Telescope Technology To Precisely Image The Glaucoma-Associated Eye Tissue

The technology originally designed to visualize stars and explore space from the grounds is now used by the Indiana University researchers to capture the first vertical microscopic image of a tissue in an eye responsible for worsening the vision-associated condition, glaucoma.

The researchers need to first visualize that particular eye tissue, known as trabecular meshwork, before finding any effective ways to treat it. The team published a research paper in the Journal of Translational Vision Science and Technology, in which it demonstrated the effective use of telescope technology in the medical sector.

IU researchers customized the currently available laser microscopic technology by incorporating a configurable mirror that can distort instantly to rectify any imperfections affecting the eye vision. The modified technology, termed as “adaptive optics,” is precise enough to visualize at the scale of Angstrom, equivalent to 10-10 Meters. Using this technology, the researchers can examine single cells within the tissue and measure the rate of blood flow through the retinal membrane.

The researchers used the same technology in computing vision distortion rate in the eye, which was designed by astronomers to rectify the atmospheric distortion, owing to which all the stars appear to twinkle.

The IU scientists informed that with the help of adaptive optics, they were able to successfully image the tissue (trabecular meshwork) within the eyes of nine volunteers selected for the study.

On a related note, Johns Hopkins Medicine scientists have come up with an approach to deliver vision-saving gene therapy to the retina by conducting multiple lab trials on monkeys, rats, and pigs. If the therapy turned out to be safe and effectual for humans, it could open a novel and everlasting passage to treat the patients suffering from age-related macular degeneration (AMD) like diseases.

The novel treatment approach involves injecting genetically engineered, harmless viruses into suprachoroidal space—the gap between the eye’s white region and vascular layer. After that, those harmless viruses infect the retinal eye cells and stably incorporate therapeutic genes.

Diane Karn
Diane Karn Subscriber
Sr. Content Writer At Market Research 24

Diane holds a Degree in Master of Advanced Study in Health Informatics. Her writings are mostly focused on developing a contemporary approach in the Healthcare sector that allows the combination of information technology, computer science, and knowledge management for the complete advancement of health services. Diane is actively present in the writing field from the last 2 years and holds a total of 4 years of experience in the Health sector. Before entering into the field of writing, she has worked as a Senior Informatics Analyst for about 2 years. At present, she serves as the Sr. Content Writer of the Health Department at Market Research 24.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *